AZBioPEERS: How to Access Small Business Grants & Commercialization Resources at the National Cancer Institute

Are you developing a promising cancer-focused technology and seeking funding to advance it toward commercialization? Join the National Cancer Institute’s Small Business Innovation Research Development Center for an informational webinar on how early-stage companies, academic spinouts, and entrepreneurial researchers can access funding and commercialization support from the National Cancer Institute (NCI). Continue reading→

BD Names Bridget Bagnato Worldwide President of Peripheral Intervention

FRANKLIN LAKES, N.J., Nov. 4, 2026 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Bridget Bagnato has been appointed worldwide president of its Peripheral Intervention business unit, effective November 16.

Based at Peripheral Intervention’s headquarters in Tempe, Arizona, Bagnato will be responsible for driving the business unit’s global strategic, operational and commercial performance. She will report to Peter Menziuso, executive vice president and president of the Interventional segment.Continue reading→

Arizona Bioscience on the Rise: Highlights from the 2026 TEConomy/BIO Report

Arizona’s bioscience industry isn’t just growing. It’s outpacing the nation.

The 2026 edition of The U.S. Bioscience Economy from TEConomy Partners and the Biotechnology Innovation Organization (BIO) gives us a fresh look at how Arizona stacks up. The short version: since 2021, our bioscience workforce has grown 13.4 percent, nearly twice the national rate of 7.0 percent. Here’s what’s driving that momentum.Continue reading→